Sep 1, 2021 ProMIS Neurosciences appoints accomplished biotechnology executive, Josh Mandel-Brehm, to its Board of Directors
Aug 18, 2021 ProMIS Neurosciences Inc. Announces Upsize of Previously Announced Public Offering of Units to US$17.5M
Jul 22, 2021 ProMIS Neurosciences to Present at 2021 Alzheimer’s Association International Conference